Harrow (HROW) Net Margin (2013 - 2026)

Harrow's (HROW) quarterly Net Margin came in at 62.44% in Q1 2026, down 2527.0% year-on-year from 2.57% in Q1 2025, and down 635.08% quarter-over-quarter from 11.67% in Q4 2025.

Harrow (HROW) Net Margin (2013 - 2026) Analysis & Trends

Harrow's Net Margin history runs 14 years deep, the most recent figure standing at 62.44% for Q1 2026.

  • On a quarterly basis, Net Margin fell 2527.0% year-over-year to 62.44% in Q1 2026; TTM through Mar 2026 was 4.16%, a 603.0% increase from a year earlier, with the FY2025 full-year figure at 1.89%, up 687.0% from the prior year.
  • Net Margin eased to 62.44% in Q1 2026 per HROW's latest filing, from 11.67% in the prior quarter.
  • Across five years, Net Margin topped out at 11.67% in Q4 2025 and bottomed at 62.44% in Q1 2026.
  • The 5-year median for Net Margin is 12.81% (2023), against an average of 15.68%.
  • Across the five-year window, Net Margin jumped 4193 bps in 2022 and slumped 3035 bps in 2023, its largest moves.
  • Year by year, Net Margin stood at 5.19% in 2022, then sank by 585 bps to 25.16% in 2023, then soared by 140 bps to 10.14% in 2024, then rose by 15 bps to 11.67% in 2025, then slumped by 635 bps to 62.44% in 2026.
  • Per Business Quant, the three latest HROW Net Margin figures stand at 62.44% (Q1 2026), 11.67% (Q4 2025), and 1.42% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn -62.44%

Historic Data

Download Data
DateValue
Mar 31, 2026 -62.44%
Dec 31, 2025 11.67%
Sep 30, 2025 1.42%
Jun 30, 2025 7.84%
Mar 31, 2025 -37.17%
Dec 31, 2024 10.14%
Sep 30, 2024 -8.57%
Jun 30, 2024 -13.23%
Mar 31, 2024 -39.22%
Dec 31, 2023 -25.16%
Sep 30, 2023 -12.81%
Jun 30, 2023 -12.64%
Mar 31, 2023 -25.45%
Dec 31, 2022 5.19%
Sep 30, 2022 -28.32%
Jun 30, 2022 -26.75%
Mar 31, 2022 -11.02%
Dec 31, 2021 -36.74%
Sep 30, 2021 -44.51%
Jun 30, 2021 -16.27%